HuMax-cMet™ is a fully human IgG1 antibody that targets the cMet oncogenic protein. cMet is the receptor for hepatocyte growth factor, which is over-expressed or shows abnormal activity in a wide variety of solid tumors. HuMax-cMet was selected from a panel of over 75 antibodies and targets the cMet protein at a unique site, binding strongly and showing anti-cancer activity in experimental laboratory and animal cancer models.